Novo Nordisk CEO on medicare coverage, new obesity pill, U.S. pricing pressure

Описание: Novo Nordisk CEO Mike Doustdar tells CNBC that Medicare coverage for obesity treatments, as well as the launch of a new obesity pill, should help boost prescription volumes and offset lower prices.

Chapters:
00:00 Introduction
00:31 Novo Nordisk’s 2026 Outlook 
6:51 EU Regulations
12:36 DOJ and FDA Support
14:41 Medical Coverage
20:00 Market share

Reporter: Annika Kim Constantino
Producer: Darren Geeter
Senior Managing Producer: Tala Hadavi
Camera by: Tara McCurrie and Shawn McMillan
Audio by: Francesco LoCascio

For access to live and exclusive video from CNBC subscribe to CNBC PRO: https://cnb.cx/42d859g

» Subscribe to CNBC TV: https://cnb.cx/SubscribeCNBCtelevision
» Subscribe to CNBC: https://cnb.cx/SubscribeCNBC
» Watch CNBC on the go with CNBC+: https://www.cnbc.com/WatchCNBCPlus

Turn to CNBC TV for the latest stock market news and analysis. From market futures to live price updates CNBC is the leader in business news worldwide.

Connect with CNBC News Online
Get the latest news: http://www.cnbc.com/
Follow CNBC on LinkedIn: https://cnb.cx/LinkedInCNBC
Follow CNBC News on Instagram: https://cnb.cx/InstagramCNBC
Follow CNBC News on Facebook: https://cnb.cx/LikeCNBC
Follow CNBC on Threads: https://cnb.cx/threads
Follow CNBC News on X: https://cnb.cx/FollowCNBC
Follow CNBC on WhatsApp: https://cnb.cx/WhatsAppCNBC

https://www.cnbc.com/select/best-cred...

#CNBC
#CNBCTV

Novo Nordisk CEO on medicare coverage, new obesity pill, U.S. pricing pressure